Evidence map›Paper›PMID 31115730›Full record

ReviewCurrent rheumatology reports2019

The Primary Cilium: Emerging Role as a Key Player in Fibrosis.

Maria E Teves, Jerome F Strauss, Paulene Sapao, Bo Shi, John Varga

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current rheumatology reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Ciliary and Non-Ciliary Roles of IFT88 in Development and Diseases.International journal of molecular sciences · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Defining the molecular fingerprint of bladder and kidney fibroblasts.American journal of physiology. Renal physiology · 2023
    Review
  8. Article
  9. Article
  10. Cilia, Centrosomes and Skeletal Muscle.International journal of molecular sciences · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Maria E TevesDepartment of Obstetrics and Gynecology, School of Medicine, Virginia Commonwealth University, 1101 E Marshall Street, Richmond, VA, 23298, USA. maria.teves@vcuhealth.org.
Jerome F StraussDepartment of Obstetrics and Gynecology, School of Medicine, Virginia Commonwealth University, 1101 E Marshall Street, Richmond, VA, 23298, USA.
Paulene SapaoDepartment of Obstetrics and Gynecology, School of Medicine, Virginia Commonwealth University, 1101 E Marshall Street, Richmond, VA, 23298, USA.
Bo ShiScleroderma Program, Division of Rheumatology, Northwestern University, 240 East Huron St., Chicago, IL, 60611, USA.
John VargaScleroderma Program, Division of Rheumatology, Northwestern University, 240 East Huron St., Chicago, IL, 60611, USA. j-varga@northwestern.edu.
Virginia Commonwealth University · USNorthwestern University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewThe myofibroblast is the culprit in the pathogenesis of fibrosis in systemic sclerosis (SSc). Activation of morphogen signaling pathways has been shown to be critically involved in organ fibrosis. Remarkably, the cellular receptors and key molecules from these signaling pathways are localized in the primary cilium. The primary cilium is a unique cellular organelle present in virtually all cells. This article summarizes recent studies evaluating the association between primary cilia and morphogen signaling driving myofibroblast transition and subsequent fibrosis. RECENT

findingsEmerging observations implicate dysfunctional primary cilia in fibrosis in many different tissues and organs. Primary cilia seem to be necessary for the initiation of the transition and sustained activation of myofibroblasts. We summarize recent progress in this field and propose the primary cilium as a potential mediator of fibrosis pathogenesis in SSc. Understanding the contributions of primary cilia in fibrosis may ultimately inform the development of entirely new approaches for fibrosis prevention and treatment.

Indexed as

AnimalsCiliaCiliopathiesFibrosisHumansMyofibroblastsScleroderma, SystemicCiliopathiesMyofibroblastsPrimary ciliaSystemic sclerosis

Identifiers

PMID31115730
OpenAlexW2945869697

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.